| Name | Title | Contact Details |
|---|
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.
Current Medical Directions is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
More than 18 years since the first Green House homes opened, THE GREEN HOUSE® Project (GHP) has come to be recognized as the leader in creating high-quality, cost-effective, and sustainable, human-scale alternatives to the traditional nursing home. The pace of momentum continues to increase, now with the majority of states having Green House homes, and potential of global expansion. By infusing the entire organization with optimal systems and structural changes that create a unified approach to elder-directed care, GHP creates a disruptive and high impact innovation. GHP means much more than simply building a small house, it is a movement that de-institutionalizes, de-stigmatizes, and humanizes care for all elders in need of long-term care.
CenterCare Inc is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kansas City Internal Medicine is a Kansas City, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.